P53 plays a regulatory role in lipogenesis and cholesterogenesis by transcriptionally inhibiting SREBP expression.50–52 Therefore, the loss of the p53 tumor suppressor may lead to increased SREBP and ACSS2 expression in all mutants. This evidence concerns the gene ACSS2 and neoplasm.